이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Blonder Tongue Laboratories 관리

관리 기준 확인 3/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Bob Palle

최고 경영자

US$26.5k

총 보상

CEO 급여 비율	n/a
CEO 임기	1.3yrs
CEO 소유권	16.8%
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	13.8yrs

최근 관리 업데이트

Recent updates

Have Blonder Tongue Laboratories, Inc. (NYSEMKT:BDR) Insiders Been Selling Their Stock?

Dec 23

CEO 보상 분석

Bob Palle 의 보수는 Blonder Tongue Laboratories 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Dec 31 2022	US$27k	n/a	-US$3m
Sep 30 2022	n/a	n/a	-US$4m
Jun 30 2022	n/a	n/a	-US$3m
Mar 31 2022	n/a	n/a	-US$656k
Dec 31 2021	US$38k	n/a	US$84k
Sep 30 2021	n/a	n/a	-US$1m
Jun 30 2021	n/a	n/a	-US$3m
Mar 31 2021	n/a	n/a	-US$6m
Dec 31 2020	n/a	n/a	-US$7m
Sep 30 2020	n/a	n/a	-US$9m
Jun 30 2020	n/a	n/a	-US$8m
Mar 31 2020	n/a	n/a	-US$8m
Dec 31 2019	US$534k	US$491k	-US$742k
Sep 30 2019	n/a	n/a	US$2m
Jun 30 2019	n/a	n/a	US$3m
Mar 31 2019	n/a	n/a	US$4m
Dec 31 2018	US$170k	US$60k	-US$1m
Sep 30 2018	n/a	n/a	-US$341k
Jun 30 2018	n/a	n/a	-US$295k
Mar 31 2018	n/a	n/a	-US$191k
Dec 31 2017	US$161k	US$42k	-US$384k

보상 대 시장: Bob 의 총 보상 ($USD 26.54K ) US 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 683.56K ).

보상과 수익: Bob 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Bob Palle (78 yo)

1.3yrs

테뉴어

US$26,542

보상

Mr. Robert J. Palle, Jr., also known as Bob, has been the Chief Executive Officer and President at Blonder Tongue Laboratories, Inc. since March 17, 2023. Mr. Palle serves as Director of Blonder Tongue Lab...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Robert Palle	CEO, President & Director	30.8yrs	US$26.54k	16.84% $ 233.3k
Gary Scharmett	Independent Director	26.5yrs	US$26.54k	1.99% $ 27.5k
James Williams	Independent Director	30.8yrs	US$26.54k	1.61% $ 22.3k
Stephen Necessary	Independent Director	6.4yrs	US$26.54k	1.34% $ 18.6k
Steven Shea	Independent Chairman	14.8yrs	US$26.54k	4.51% $ 62.5k
Charles Dietz	Independent Director	12.8yrs	US$26.54k	2.02% $ 28.0k
John Burke	Independent Director	4.4yrs	US$26.54k	0.027% $ 370.8
Michael Hawkey	Independent Director	4yrs	US$26.54k	0.076% $ 1.1k

13.8yrs

평균 재임 기간

66.5yo

평균 연령

경험이 풍부한 이사회: BDRL 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 13.8 년).

Blonder Tongue Laboratories 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

Blonder Tongue Laboratories, Inc. Announces the Retirement of Stephen K. Necessary from the Board

Blonder Tongue Laboratories, Inc. Announces President Changes

Blonder Tongue Laboratories, Inc. Announces Furloughing Ronald V. Alterio, the Senior Vice President-Engineering and Chief Technology Officer

Blonder Tongue Laboratories, Inc. Announces Resignation of Anthony Bruno as BOD, Effective from May 25, 2022

Blonder Tongue Laboratories, Inc., Annual General Meeting, May 25, 2022

Blonder Tongue Laboratories, Inc. Announces Retirement of James H. Williams as Member of the Board of Director

Recent updates

Blonder Tongue Announces IP Failover Feature Added to NXG Video Delivery System

Blonder Tongue Laboratories, Inc. Announces the Retirement of Stephen K. Necessary from the Board

Blonder Tongue Laboratories, Inc. Announces President Changes

Blonder Tongue Laboratories, Inc. to Report Q3, 2022 Results on Nov 04, 2022

Blonder Tongue Laboratories Announces Product Standardization with Tier One Broadband Cable Operator

Blonder Tongue Laboratories, Inc. to Report Q2, 2022 Results on Aug 15, 2022

Blonder Tongue Laboratories, Inc.(OTCPK:BDRL) dropped from S&P TMI Index

NYSE American to Suspend Trading Immediately in Blonder Tongue Laboratories

Blonder Tongue Laboratories, Inc. Announces Furloughing Ronald V. Alterio, the Senior Vice President-Engineering and Chief Technology Officer

Blonder Tongue Laboratories, Inc. Announces Resignation of Anthony Bruno as BOD, Effective from May 25, 2022

Blonder Tongue Laboratories, Inc., Annual General Meeting, May 25, 2022

Blonder Tongue Laboratories, Inc. Announces Retirement of James H. Williams as Member of the Board of Director

NYSE American to Commence Delisting Proceedings Against Blonder Tongue Laboratories

Independent Director Rick Briggs has left the company

Independent Director recently sold US$102k worth of stock

Third quarter 2021 earnings released: US$0.016 loss per share (vs US$0.18 loss in 3Q 2020)

Second quarter 2021 earnings released: EPS US$0.14 (vs US$0.12 loss in 2Q 2020)

Director recently sold US$74k worth of stock

First quarter 2021 earnings released: US$0.036 loss per share (vs US$0.21 loss in 1Q 2020)

Full year 2020 earnings released: US$0.76 loss per share (vs US$0.077 loss in FY 2019)

Independent Director recently sold US$77k worth of stock

Blonder Tongue Laboratories, Inc. announced that it has received $0.6 million in funding

New 90-day high: US$1.85

MD of Strategic Accounts & Director recently sold US$52k worth of stock

Have Blonder Tongue Laboratories, Inc. (NYSEMKT:BDR) Insiders Been Selling Their Stock?

Blonder Tongue Laboratories Receives Non-Compliance Letter from NYSE American

New 90-day high: US$1.75

Third quarter 2020 earnings released: US$0.18 loss per share

New 90-day high: US$1.50

NYSE Accepts Compliance Plan of Blonder Tongue Laboratories, Inc

New 90-day high - US$1.35

Earnings released

Blonder Tongue Laboratories, Inc. to Report Q2, 2020 Results on Aug 07, 2020

CEO 보상 분석

CEO

테뉴어

보상

이사회 구성원

평균 재임 기간

평균 연령